CLHIA expresses concerns to Federal Health Minister about costs of a national pharmacare program


Date de parution : 09/22/2015
Personne(s)-ressource(s) : Stephen Frank

September 22, 2015

Hon. Rona Ambrose
Minister of Health
70 Colombine Driveway, Tunney's Pasture
Postal Location: 0906C
Ottawa, ON K1A 0K9

Dear Minister Ambrose:

Re: Facts about the cost implications of bringing prescription drugs into Medicare

I am writing to provide some important facts related to the recent discussions about potential pharmacare reform in Canada. As part of this dialogue, some have argued that prescription drugs should be included in Canada's Medicare system on the same basis as hospital and physician costs. One argument that has been put forward by some is that this would result in many billions of dollars of savings and could be achieved with only a small incremental net increase in government expenditures. The research underpinning these claims has significant errors, not the least of which is that it ignores the transition costs of any such change. The reality, as we document below, is that if prescription drugs were included under Medicare on the same basis as physician and hospital costs, there would be an immediate $14.1 billion gap that governments would be required to address.